SciELO - Scientific Electronic Library Online

vol.7 issue1Endothelial dysfunction and inflammation in chronic and acute heart failure author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Insuficiencia cardíaca

On-line version ISSN 1852-3862


FLORIO, Lucía; VIGNOLO, Gustavo; CENTURION, Raúl  and  POUSO, Jorge. Systemic vascular resistance by echocardiography in chronic heart failure: a tool to optimize the dose of ACE inhibitors and ARBs: uma ferramenta para otimizar a dose de inibidores da IECA e BRA II. Insuf. card. [online]. 2012, vol.7, n.1, pp.2-9. ISSN 1852-3862.

Background. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improve heart failure prognosis, but many patients are not treated with target doses. Objective. Our aim was to determine if the echocardiographic measurement of systemic vascular resistance could increase the number of patients treated with optimal doses. Material and methods. Patients with heart failure due to systolic dysfunction and no contraindications to enalapril/ losartán were included. The target doses considered were enalapril/losartán ≥ 20/25mg/day. Patients were randomized to adjusted dose using clinical approach and systemic vascular resistance vs clinical parameters only (Groups A and B). In group A if systemic vascular resistance was ≥ 1200 dynes.sec/cm-5, enalapril dose was increased 25% up to 40mg and then losartán was added (unless contraindication). The main outcome measures in follow-up were changes in proportion of patients receiving enalapril/losartán target doses, comparing recruit vs last control in both groups. Results. Seventy patients (50 males, age 60±12 years old, 30 in functional class I, systemic vascular resistance 2033±802, were included and followed-up for 12.3±months. There were no significant basal differences between groups. In group A significant increase was observed in the proportion of patients receiving target dose of enalapril/losartán (50% recruit vs 64% last control, p < 0.01). In group B a significant decrease was observed in the same proportion (59% vs 47%, p <0.05). Conclusion. More patients with heart failure received target doses of enalapril/losartán, when echocardiographic measurement of systemic vascular resistance was used.

Keywords : Heart failure; Systemic vascular resistance; Echocardiography; Converting enzyme inhibitors.

        · abstract in Spanish | Portuguese     · text in Spanish


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License